-
Did you mean
- clinical diagnost
- clinical diagnostics
-
C-Peptide ELISACatalog #: 80-CPTHU-E01.1
Sensitivity: 2.95 pmol/L
Range: 20 - 3000 pmol/L
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
C-Peptide ELISA Jumbo Pack (10 Plates)
Catalog #: 80-CPTHU-E10
Sensitivity: 2.95 pmol/L
Range: 20 - 3000 pmol/L
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
C-Peptide Chemiluminescence ELISACatalog #: 80-CPTHU-CH01
Sensitivity: <4.32 pg/mL
Range: 4.5 - 12,960 pg/mL
Sample Types: EDTA Plasma, Heparin Plasma, Plasma, Serum, Tissue Culture
Sample Size(s): 96 Wells
Detection: Chemiluminescence -
C-Peptide Chemiluminescence ELISA Lab Pack (5 Plates)Catalog #: 80-CPTHU-CH05
Sensitivity: <4.32 pg/mL
Range: 4.5 - 12,960 pg/mL
Sample Types: EDTA Plasma, Heparin Plasma, Plasma, Serum, Tissue Culture
Sample Size(s): 5 x 96 Wells
Detection: Chemiluminescence -
Insulin ELISA
Catalog #: 80-INSHU-E01.1
Sensitivity: 0.399 µIU/mL
Range: 3 - 200 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Ultrasensitive Insulin ELISA
Catalog #: 80-INSHUU-E01.1
Sensitivity: 0.135 µIU/mL
Range: 0.15 - 20 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Ultrasensitive Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSHUU-E10
Sensitivity: 0.135 µIU/mL
Range: 0.15 - 20 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSHU-E10.1
Sensitivity: 0.399 µIU/mL
Range: 3 - 200 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Calprotectin Immunoturbidimetric Assay
Catalog #: 80-CALPHU-IT200
Sample Types: Stool
Sample Size(s): Other
-
Calprotectin Chemiluminescence ELISACatalog #: 80-CALPHU-CH01
Sensitivity: 7.9 ug/g
Range: 7.9 - 6,000 ug/g
Sample Types: Stool
Sample Size(s): 96 Wells
Detection: Chemiluminescence -
Anti-SLA IgG ELISA
Catalog #: 35-SLAHU-E01
Sensitivity: 1.0 U/mL
Range: 3 - 300 U/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Immunoscan CCPlus® (Anti-CCP ELISA)
Catalog #: 13-RA-96PLUS
Sensitivity: Semi-quantitative; see protocol
Range: 25-3200 U/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric
Alpco Home Page
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.Supporting your work with life science and clinical testing productsVIEW ALL LIFE SCIENCE PRODUCTSVIEW ALL CLINICAL DIAGNOSTIC PRODUCTS
Tips & Tricks
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
Company Overview
Accuracy and Efficiency. Together.We are a leading global developer and provider of innovative molecular and immunodiagnostic products focused on Infectious and Gastroenterological Diseases. We are a trusted partner creating value for research and clinical laboratories with high-quality, user-frien...
Quality
Quality Policy and Standards“ALPCO is committed to producing in vitro diagnostic devices that exceed its customers’ expectations. This is accomplished by maintaining an effective quality management system and operating in compliance with its rigorous requirements. This commitment is evidenced by the...
Complement System Solutions for Drug Development and Clinical Research
Datasheet: Complement System Immunoassays
Download
The complement system is essential to innate immunity which protects from chronic, autoimmune, and infectious disease. There are three distinct pathways of complement activation: classical, lectin/MBL, and alternative. Each leads...
Simplify Stool Sample Processing
Introduction
We understand the challenges facing lab managers and directors who need to continuously improve workflow efficiency and implement new tests and technologies to be competitive. Our unique extraction method can be used with a portfolio of targeted stool markers. This allows your lab to s...
Stool-Based Biomarkers to Differentiate Between IBD and IBS
What are IBD and IBS?
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues affecting millions of people every day. Although there is some overlap between symptoms of IBD and IBS, differences still remain in regards to pathologies, risks...
[Infographic] The Benefits of Therapeutic Drug Monitoring for IBD
The Burden of Inflammatory Bowel Disease in the US and Canada
More than 1 million people in the US and 200,000 people in Canada are currently living with inflammatory bowel disease (IBD). This number is projected to grow exponentially over the next 10 years1,2. As the prevalence of IBD increases, s...
The Impact of Adiponectin in NAFLD and NASH Research
Date: March 7, 2017
Lately, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have been widely discussed in both the clinical and research communities. Some of the focus has been related to alternative research methods that can improve diagnostic and monitoring meth...
ALPCO’s Quality Management System Receives ISO 13485:2016 Certification
October 8, 2018
ALPCO recently announced that its quality management system received the distinguished ISO 13485:2016 certification from Intertek. ALPCO’s certification applies to the design, development, manufacture, and distribution of in vitro diagnostic reagents and kits.
The Internati...
Ampersand Capital Partners Acquires American Laboratory Products Company
FOR IMMEDIATE RELEASE
Salem, NH – September 21, 2020: American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s wo...
Enhance Your Lab’s Molecular GI Portfolio
Molecular GI testing for bacteria such as salmonella, vibrio, and E. coli, and viral pathogens including norovirus and rotavirus, is instrumental in the diagnosis and treatment of infection and dysbiosis. In addition, many gastrointestinal disorders often require protein biomarker tests to aid in ac...
GI Testing
Calprotectin Chemiluminescence ELISA (80-CALPHU-CH01)
The Calprotectin Chemiluminescence ELISA is an in vitro diagnostic chemiluminescent assay intended for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human sto...
Webinar on Demand: Molecular Allergy Diagnostics – Principles and Methodology
Our speaker from MacroArray Diagnostics, Christian Lupinek, MD, discusses Molecular Allergy Diagnostics – Principles and Methodology.
Watch Now
In the webinar “Molecular Allergy Diagnostics – Principles and Methodology,” the basic principles of component-resolved allergy diagnosis, especia...
The Role of IgE and IgG in Allergy Testing
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives...
Diagnostic Testing in GI Health
60 to 70 million Americans are affected by gastrointestinal (GI) diseases and disorders each year. The estimated annual U.S. cost associated with GI disorders is over 140 billion dollars. Gl diseases and disorders can have a significant impact on quality of life, often contributing to anxiety ...
Understanding Exocrine Pancreatic Insufficiency
Pancreatic Elastase (PE) Testing for Determination of Exocrine Pancreatic Insufficiency (EPI)
Advantages of ALPCO PE Testing for Determination of EPI
• No interference from PERT
• Single sample collection without dietary restriction
• Detection of both CELA3A and CELA3B isoforms
• Compatibi...
Life Science and Clinical Diagnostics Solutions
Product Portfolio: Over 600 Kits to Measure Important Biomarkers. We are continuously expanding our portfolio of life sciences and clinical diagnostic solutions in support of the research community. ALPCO currently offers over 600 kits to measure important biomarkers in multiple species and sample t...
Thermo Fisher partners with ALPCO-GeneProof to broaden their CE-IVD molecular assay portfolio
BRNO, CZECH REPUBLIC, April 17, 2023 – ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with...
ALPCO-GeneProof Appoints Erik M. Allen as Chief Executive Officer
SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr....
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives...
ELISAs for CHO Host Cell Proteins
Chinese Hamster Ovary (CHO) cells are the most dependable and most popular host cells for the industrial production of biotherapeutics. They are stable cell lines that are adaptable to a wide range of culture conditions and routinely produce very high protein and antibody yields. More importantly,...
ALPCO receives FDA 510(k) clearance for the Calprotectin Immunoturbidimetric Assay
SALEM, NH, June 15, 2023 - American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay.